Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram crossover study of myoclonus and psychiatric comorbidity in dystonia
NL-OMON34645Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of escitalopram in dystonia, major depressive disorder (MDD), anxiety disorder and 1 more (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Dopamine and serotonin binding differences versus healthy controls and Clinical global improvement in jerks. Started Jul 2010; status: active, not recruiting.
02
Drugs
escitalopram
03
Conditions
dystoniamajor depressive disorder (MDD)anxiety disorderobsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON34645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34645.